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(IWII) presented a revision of the wound infection 
continuum that aligned the phases of infection 
with the clinical response of the individual and 
the wound (IWII, 2016). The wound infection 
continuum revision was developed using a 
consensus voting (Delphi) process underpinned 
by a literature review. In an iterative, three-round 
voting process, experts from the IWII executive 
committee reached agreement on wound 
infection definitions and terminology, as well as an 
update on the conceptualisation and presentation 
of the wound infection continuum (IWII, 2016). 
This process, which used a previously validated 
and published method, allowed the participants 
to reach agreement on statements using a valid 
and reliable that had been adapted to an online 
process (Haesler et al, 2018).
The first phase of the wound continuum is 
considered to be contamination. This recognises 
the well-established fact that all wounds acquire 
micro-organisms, often from normal flora from the 
periwound skin. However, if the wound bed does 
not provide an appropriate environment for the 
microbials species they will no multiply or persist, 
and their presence is neither detrimental nor 
persistent (Cooper, 2005; IWII, 2016).
Contamination describes the point at which 
microbial species successfully grow and divide. 
At this point, microbes being to proliferate in a 
favourable environment, but are not in sufficient 
levels or virulence to disturb wound healing or 
provoke an immune response (Dow et al, 1999; 
Enoch and Harding, 2003). There are no clinical 
signs and symptoms as the healing trajectory 
continues as expected; however, laboratory 
Wound infection is defined as the presence of a wound environment characterised by microbes in sufficiently 
large numbers, or of sufficient virulence to provoke 
an immune response locally, systemically or both. 
Whenever there is a break in the skin integrity, 
bacteria can enter the body and begin multiplying. 
Without the protective barrier of the skin, sensitive 
tissues in the wound bed are vulnerable to 
microbial colonisation. When microorganisms 
invade a wound and start proliferating, local tissue 
damage occurs and wound healing is disrupted 
(Eberlein, 2006; Siddiqui and Bernstein, 2010).
Update to the wound infection 
continuum 
The wound infection continuum characterises the 
progression of infection in a wound. A ‘continuum’ 
is a continuous sequence in which adjacent 
elements are not perceptibly different from 
each other, but the extremes are quite distinct 
(Merriam-Webster Online Dictionary, 2018). This 
conceptualisation of the impact that infection 
has on a wound and the person with a wound 
as a continuum recognises that distinct stages 
of infection are difficult to define and identify. 
However, there is a large and easily distinguishable 
difference between a non-infected wound and 
an individual with systemic infection arising from 
microbes in a wound. 
As stages of infection cannot be neatly 
demarcated, there has been ongoing debate 
about the distinct wound infection stages and 
their relationship to clinical signs and symptoms. In 
2016, the International Wound Infection Institute 
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specimens from the wound would confirm 
microbes in proliferating numbers.
The term ‘critical colonisation’ has previously 
been included into the wound infection continuum 
as a stage following contamination. The term was 
used to refer to growth of bacteria within a chronic 
wound without causing the signs and symptoms 
traditionally associated with infection (Edwards 
and Harding, 2004). The stage is considered to be 
when a chronic wound displays signs of delayed 
healing, and the term implies that a critical number 
or virulence of microbials has been reached. 
However, the literature provides no guidance on 
what this critical level may be, and the term ‘critical 
colonisation’ has remained poorly defined (White 
and Cutting, 2005; White et al, 2006). The difficulty 
Figure 1. The International Wound Infection Institute’s Wound Infection Continuum and associated signs and symptoms of wound infection 
stages (reproduced with permission) (Edwards and Harding, 2004; WUWHS, 2008; Lipsky and Hoey, 2009).
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undermining can occur. Friable granulation tissue 
can occur due to bacterial burden interfering with 
healthy collagen formation (Sibbald et al, 2003). 
Because the classic Celsian signs of local wound 
infection are generally easy to detect by simply 
visualising the wound bed, the IWII refers to this 
stage on the wound infection continuum as overt 
(classic) signs of local infection (IWII, 2016).
Beyond the wound — later stages of the 
wound infection continuum
When pathogens proliferate beyond the bounds 
of the wound, spreading infection has occurred 
(World Union of Wound Healing Societies 
[WUWHS], 2008; Leaper et al, 2012). If uncontained 
by the host response, microbial infection begins 
to spread beyond the wound into other local 
structures, including deeper tissue, surrounding 
tissue, muscle, fascia and local organs. The immune 
response to wound infection also becomes evident 
outside the bounds of the wound. Signs and 
symptoms of spreading infection include extending 
erythema, extending induration, crepitus and 
inflammation of the lymph glands and lymphatic 
vessel walls (lymphangitis). 
The individual might lose their appetite and 
experience malaise, lethargy and other non-
specific deterioration (WUWHS, 2008; Leaper 
et al, 2012; IWII, 2016). During this phase, the 
wound bed continues to experience dehiscence 
with or without satellite lesions of infection 
breakdown, while the overt signs of local wound 
infection remain apparent.
Systemic infection is said to occur when the 
impact of wound infection is on the body as a 
whole (WUWHS, 2008; Leaper et al, 2012; IWII, 
2016). Microbials that entered the host through the 
wound bed gradually proliferate until they extend 
throughout the body via the vascular or lymphatic 
systems (WUWHS, 2008; Leaper et al, 2012; IWII, 
2016). Clinical signs and symptoms of this invasion 
reflect systemic inflammatory response from the 
host, including severe sepsis and septic shock, 
organ failure and death.
Biofilm in the wound infection 
continuum
The revised wound infection continuum recognises 
the advancing knowledge on biofilm in chronic 
wounds and its relationship to both microbial 
action and clinical signs and symptoms. It is now 
recognised that as microbials increase in number 
and virulence, biofilm form, mature and continually 
disperse (Cutting and McGuire, 2015; Nouraldin et 
al, 2016; Uppuluri and Lopez-Ribot, 2016). Biofilm 
is likely to be present in chronic wounds that have 
sufficient bacterial virulence or numbers to evoke 
in determining when critical colonisation is 
reached led the IWII Executive Committee to reach 
agreement to remove this term from the revised 
wound infection continuum (IWII, 2016) (see the 
revised continuum in Figure 1).
Local wound infection — covert and 
overt signs and symptoms
When bacteria or other microbes present in the 
wound move deeper into wound tissue and 
proliferate in a way that overwhelms the immune 
system (Collier, 2004; Siddiqui and Bernstein, 2010), 
colonisation progresses to local infection. In this 
stage, infection is maintained within the bounds 
of the wound bed, contained in the one location, 
system or structure. 
Local wound infection often presents in a subtle 
manner that may not be readily identified without 
conscientious wound assessment and a strong 
understanding of early indicators that bacteria 
may be present in quantities or virulence that 
are a threat (Sibbald et al, 2006; 2007). Wound 
breakdown, delayed healing, new pocketing and 
epithelial bridging are early signs that tissue is not 
healing along the optimal trajectory (Cutting and 
Harding, 1994; Gardner et al, 2001; Collier, 2004; 
Gardner and Frantz, 2008).
Recognising the earliest signs and symptoms of 
wound infection is essential. Intervening promptly 
with appropriate infection management strategies 
is important for preventing more extensive local 
tissue damage and avoiding further microbial 
proliferation, delays to wound healing and 
potential severe sequalae. These early and subtle 
indicators of local wound infection gradually 
emerge (particularly in chronic wounds) and are, 
therefore, referred to in the 2016 update of the 
Wound Infection in Clinical Practice consensus 
document (IWII, 2016) as covert signs of infection.
Further along the wound infection continuum, 
when the host response to microbial invasion 
increases, the classic signs of local wound infection 
become evident. Purulent discharge, erythema and 
swelling, local warmth, increasing malodour and 
new or increasing pain are classic signs of infection 
in any organ of the body (Sibbald et al, 2003; IWII, 
2016). The classic signs of local wound infection 
reflect the host’s inflammatory response. As the 
host responds, the increase in local blood flow 
causes a local warmth. Erythema and pain develop 
due to activation of vasoactive mediators (e.g. 
histamine). Purulence and malodour are produced 
by bacteria processes (IWII, 2016).
In wounds, these classic signs of infection are 
also accompanied by delays in wound healing 
beyond expectations. When bacteria inhibit 
the development of healthy granulation tissue, 
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having the clinical skills to identify covert signs 
of infection is an advantage. When the earliest 
indicators of local infection are evident, more 
aggressive treatment should be initiated. This 
generally includes the use of topical antimicrobial 
therapies, including antibacterial wound dressings 
and topical antiseptics (Leaper et al, 2012).
Antiseptics are non-selective solutions that 
disrupt the ability of microbials to proliferate. 
However, antiseptics have potential adverse 
effects, as some are cytoxic (may kill healthy 
wound tissues). As cytotoxicity is thought to be 
concentration dependent (Siddiqui et al, 2010; 
Leaper et al, 2012), antiseptic use is recommended 
at the lowest concentration, and preparations 
that cause more excessive tissue damage (e.g. 
hydrogen peroxide and sodium hypochlorite) are 
no longer recommended (IWII, 2016). A wide range 
of antiseptics appropriate for use in the stages of 
covert local infection, overt local infection and 
beyond are described in the 2016 update of the 
Wound Infection in Clinical Practice document, 
including more guidance on their indications and 
use (IWII, 2016).
Although antibiotic therapy is not 
recommended for routine use in promoting 
wound healing, judicious use of antibiotics when 
wound overt signs of wound infection are present 
and there is microbial confirmation of causative 
agent and its sensitivities (Gürgen, 2014). The 
global crisis of increasing antibiotic resistance 
(World Health Organization, 2014; Centers for 
Disease Control and Prevention, 2016) requires 
that all antibiotic use be reserved for situations 
in which local interventions are insufficient to 
control infection. 
Conclusion
The revision of the wound infection continuum 
continues to recognise the stage on the wound 
infection continuum previously referred to as 
‘critical colonisation’. Recognising this stage as 
covert local infection changes the focus from an 
undefined level of bacterial proliferation to the 
clinical signs and symptoms associated with an 
early inflammatory response from the host. Having 
the skills and confidence to identify the early, 
covert signs of infection is important, as reacting 
early to indicators suggesting that the person’s 
immune response is overwhelmed prevents severe 
sequalae of untreated local wound infection. Being 
able to identify when vigilance should become 
active intervention is imperative to providing rapid 
and appropriate management with cleansing 
and debridement, topical antiseptics and, in 
cases where the local therapy is inadequate, 
systemic antibiotics.  Wint
an inflammatory and immune response from 
the host.
Clinical signs and symptoms that biofilm may 
be present reflect those of early local infection, 
including increasing exudate and moisture, 
low level inflammation and erythema, poor 
granulation or friable hypergranulation. Biofilm 
may be present, especially in chronic wounds 
that have delayed healing in optimal conditions, 
recalcitrance to antimicrobial therapy and failure of 
appropriate antibiotics to resolve symptoms. These 
clinical indicators of potential biofilm presence 
in a chronic wound were agreed on by the IWII 
Executive Committee using a formal Delphi 
process and underpinned by a literature review of 
the current scientific evidence (IWII, 2016).
When the clinical indicators listed above are 
present, biofilm-based wound care, which includes 
appropriate cleansing, wound bed debridement 
and topical antiseptics, is an appropriate course 
of management (Rhoads et al, 2008; Leaper et al, 
2012; Wolcott, 2015; Bianchi et al, 2016). The 2016 
update of the Wound Infection in Clinical Practice 
document outlines implementation of these 
interventions to address biofilm-based wound care 
strategies to best effect (IWII, 2016).
Addressing wound infection
In addition to outlining the stages of wound 
infection as they relate to the pathophysiological 
action of microbials increasing in number and 
vigilance, the wound infection continuum provides 
guidance on interventions that are appropriate at 
each stage. 
In the early stages, when microbial colonisation 
has not interfered with the host’s health or 
the wound healing process, being alert to the 
risks of local infection is important. In these 
(and other) stages on the wound infection 
continuum, implementing strategies to prevent 
cross-infection, facilitating wound drainage, 
using antimicrobial dressings and optimising the 
wound bed environment, all optimise healing and 
reduce the risk of the wound being overcome by 
bacterial proliferation.
Optimising the health of the individual, 
including management of comorbidities and 
optimisation of nutritional status, is important 
to strengthening the potential of the immune 
response to respond rapidly and effectively 
(WUWHS, 2007; Australian Wound Management 
Association and New Zealand Wound Care Society, 
2012; National Pressure Ulcer Advisory Panel et al, 
2014; Lipsky et al, 2016).
When signs of local wound infection emerge, 
rapid response with appropriate management 
strategies is an imperative. It is at this point that 
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